Gastroretentive Drug Delivery Systems Outsourcing Global Market 2024 To Reach $1.89 Billion By 2028 At Rate Of 8.0%
The Business Research Company's Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2023 – Market Size, Trends, Global Forecast 2023-2032
LONDON, GREATER LONDON, UK, July 29, 2024 /EINPresswire.com/ -- The gastroretentive drug delivery systems outsourcing market has experienced robust growth in recent years, expanding from $1.29 billion in 2023 to $1.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the rising incidence of stomach and small intestine disorders, rising drug delivery systems, rising prevalence of gastric cancer, rise in government initiatives, and increase in the number of hospitals.
Strong Future Growth Anticipated
The gastroretentive drug delivery systems outsourcing market is projected to continue its strong growth, reaching $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increase in the number of ambulatory centers, the focus on patient compliance and convenience, the rising incidence of chronic diseases, increasing personalized medicine, and the growing aging population.
Explore Comprehensive Insights Into The Global Gastroretentive Drug Delivery Systems Outsourcing Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15813&type=smp
Growth Driver Of The Gastroretentive Drug Delivery Systems Outsourcing Market
The rising prevalence of gastrointestinal disorders is expected to propel the growth of the gastroretentive drug delivery systems outsourcing market going forward. Gastrointestinal disorders refer to a wide range of diseases affecting the digestive tract, which includes the stomach, liver, gallbladder, intestines, and pancreas. Gastrointestinal disorders are rising due to aging populations, antibiotic use, infectious agents, dietary changes, stress and lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems provides pharmaceutical companies with the resources and expertise needed to address the growing burden of gastrointestinal disorders, ultimately improving patient outcomes and quality of life.
Make Your Report Purchase Here And Explore The Whole Industry's Data As Well:
https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report
Major Players And Market Trends
Key players in the gastroretentive drug delivery systems outsourcing market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc.
Major companies operating in the gastroretentive drug delivery systems outsourcing market are focused on developing innovative products, such as proton pump inhibitors, to enhance drug delivery efficiency and patient convenience. Proton pump inhibitors (PPIs) are a class of medications commonly used to treat conditions related to excessive stomach acid production.
Segments:
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Geographical Insights: North America Leading The Market
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Gastroretentive Drug Delivery Systems Outsourcing Market Definition
Gastroretentive drug delivery systems outsourcing refers to the practice of pharmaceutical companies contracting with external service providers or contract research organizations (CROs) to develop and manufacture drug delivery systems designed to prolong the residence time of medications within the gastrointestinal (GI) tract. These systems are engineered to enhance drug absorption, improve therapeutic efficacy, and optimize patient outcomes.
Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 20241 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on gastroretentive drug delivery systems outsourcing market size2, gastroretentive drug delivery systems outsourcing market drivers and trends, gastroretentive drug delivery systems outsourcing market major players, gastroretentive drug delivery systems outsourcing competitors' revenues, gastroretentive drug delivery systems outsourcing market positioning, and gastroretentive drug delivery systems outsourcing market growth across geographies. The gastroretentive drug delivery systems outsourcing market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Intranasal Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report
Connected Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report
Nasal Drug Delivery Technology Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report
About The Business Research Company3
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
WATCH NOW: Healthcare Services Industry Coverage & Solutions - The Life Sciences Research Company at http://www.youtube.com/watch?v=nnWp-1rnmgY
![](https://i.ytimg.com/vi/nnWp-1rnmgY/hqdefault.jpg)
1 https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report
2 https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report
3 https://www.thebusinessresearchcompany.com/
![](https://www.einpresswire.com/tracking/article.gif?t=4&a=O6O_fQU_Bhcg8KV7&i=1_xTP0wFp0w60s5F)